Friday, November 28, 2025 | 03:29 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Here's why AstraZeneca Pharma share price is down over 2% today

The decline in the company's share price came as its shares traded ex-date following the announcement of a ₹32 per share dividend

pharma

SI Reporter New Delhi

Listen to This Article

Don't want to miss the best from Business Standard?

AstraZeneca Pharma share price: Shares of pharma major AstraZeneca Pharma India dropped 2.5 per cent to ₹9,165 per share during intraday deals on Friday and continued to trade lower. At around 2:20 PM, they were trading at approximately ₹9,165 per share, down 2.10 per cent from their previous close of ₹9,394 on the NSE. A combined nearly 0.17 lakh equity shares of AstraZeneca Pharma, estimated to be worth around ₹16 crore, changed hands on the BSE and NSE.

Here's why AstraZeneca Pharma’s share price declined today

The decline in the company’s share price came as the company's shares traded ex-date following its announcement of dividend rewards of ₹32 per share for the financial year 2024–25 (FY25). Notably, the ex-dividend date marks the day a stock begins trading without the value of its declared dividend. To be eligible for the dividend, investors must own the stock before the ex-dividend date.
 

Make smarter market moves with The Smart Investor. Daily insights on buzzing stocks and actionable information to guide your investment decisions delivered to your inbox.

AstraZeneca Pharma dividend record date

The pharma company fixed the record date as today, July 18, to ascertain shareholders' eligibility for participation in the dividend announcement. 

AstraZeneca Pharma dividend history

The company has a strong history of awarding dividends. According to NSE data, it paid ₹8 per share in 2022, ₹16 per share in 2023, and ₹24 per share in 2024 to its shareholders.

AstraZeneca Pharma dividend yield

At the current market price, AstraZeneca Pharma has a dividend yield of 0.35 per cent.

About AstraZeneca Pharma

AstraZeneca Pharma, a subsidiary of AstraZeneca Plc (UK), is engaged in the manufacture, distribution, and marketing of pharmaceutical products, and coordinates clinical trial services with its overseas group company. The company operates across major therapeutic areas including oncology, alimentary & metabolism, cardiovascular, renal diabetes, respiratory, infections, neuroscience, and inflammation. As of July 18, the pharma major boasts a market capitalisation of ₹22,912.50 crore on the NSE. 
 

AstraZeneca Pharma share price history

AstraZeneca Pharma's share price has appreciated 42 per cent year-to-date, compared to a 5 per cent gain in the benchmark Nifty50 during the same period. The shares scaled a 52-week high of ₹10,691 on June 13, 2025, and hit a 52-week low of ₹6,220 on November 21, 2024, on the NSE.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 18 2025 | 2:38 PM IST

Explore News